Exelixis Updates Phase 1b COSMIC-021 Trial of Cabozantinib in Combination With Atezolizumab in Patients With Advanced Solid Tumors, Says Adding 4 Cohorts Due to Encouraging Early Data
Benzinga Newsdesk